Literature DB >> 11666144

Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.

S Wang1, G E Berge, N O Hoem, R B Sund.   

Abstract

The dog is able to synthesise ascorbic acid (AA), but is frequently given the vitamin in an attempt to improve health and performance. The pharmacokinetics of AA in this species, however, are not well studied. Using a selective analytical method and careful stability control, the pharmacokinetics of orally given AA was studied in 20 dogs, at two dosage levels (15 and 50 mg kg(-1)) and with two forms of supplement [crystalline AA and the vitamin C product Ester-C(Inter-Cal Corp., Prescott, AZ, USA)]. After oral administration, a rapid increase was found in the plasma level of AA, indicating a possible intestinal active transport mechanism in this species. The obtained C(max)and AUC values were found to increase in a non-linear fashion when the dose of AA was increased. The pharmacokinetic modeling of the elimination of AA was made difficult by a pronounced secondary peak appearing after about 9 hours. The comparison of crystalline AA and Ester-C did not indicate any significant differences in pharmacokinetic parameters between the two preparations of the vitamin. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11666144     DOI: 10.1053/rvsc.2001.0480

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs.

Authors:  Margaret L Musser; Alyssa L Mahaffey; Melissa A Fath; Garry R Buettner; Brett A Wagner; Benjamin K Schneider; Yeon-Jung Seo; Jonathan P Mochel; Chad M Johannes
Journal:  Front Vet Sci       Date:  2019-11-07

2.  Effects of administration of ascorbic acid and low-dose hydrocortisone after infusion of sublethal doses of lipopolysaccharide to horses.

Authors:  Melinda J Anderson; Alina S Ibrahim; Bruce R Cooper; Andrew D Woolcock; George E Moore; Sandra D Taylor
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.